Insider Transactions in Q1 2025 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+9.24%
|
$100,000
$2.24 P/Share
|
|
Jan 02
2025
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,600
-3.81%
|
-
|
|
Jan 02
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,105
+13.16%
|
-
|
|
Jan 02
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,941
-41.2%
|
-
|
|
Jan 02
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,138
+50.0%
|
-
|